Endocrinology, Vol 123, 2048-2053, Copyright © 1988 by Endocrine Society

ARTICLES

Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats

SM Brichard, W Okitolonda and JC Henquin
Unite de Diabetologie et Nutrition, University of Louvain, Faculty of Medicine, Brussels, Belgium.

The trace element vanadium (V) exerts insulin-like effects in vitro. The present study examined its effects on glucose homeostasis in rats made diabetic by streptozotocin. Na3VO4 (0.2 or 0.5 mg/ml) was administered ad libitum in drinking water. Fed plasma glucose levels (approximately 26 mmol/liter) fell by 30% and 56% after 5 days of treatment with the low (VO.2) and high (VO.5) concentrations of vanadate, respectively. This decrease was not due to a rise in peripheral insulin levels and persisted for more than 2 months. Daily glucosuria was decreased by 60% and 85% in VO.2 and VO.5 rats, respectively. Tolerance of the rats to oral or iv glucose was also considerably improved by vanadate; integrated glucose responses were about 55% and 75% lower in VO.2 and VO.5 rats than in controls, and the differences were not due to restoration of insulin release. Compared to nondiabetic rats, pancreatic insulin reserves amounted to 1% in untreated rats, 3% in VO.2 rats, and 6% in VO.5 rats after 9 weeks of treatment. Liver, but not muscle, glycogen was increased by vanadate. Despite improvement of their diabetic state, vanadate-treated rats did not gain more weight than untreated rats. Their food intake (corrected for urinary glucose losses) was decreased by about 25%. No signs of altered kidney or liver function were observed in rats receiving vanadate. In conclusion, vanadate markedly improves glucose homeostasis in streptozotocin-diabetic rats by an insulin-like mechanism, but does not reproduce the anabolic effects of the hormone.

This article has been cited by other articles:

				M M Conradie, H de Wet, D D R Kotze, J M Burrin, F S Hough, and P A Hulley Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo J. Endocrinol., November 1, 2007; 195(2): 229 - 240. [Abstract] [Full Text] [PDF]

				J. Wilsey, M. K. Matheny, and P. J. Scarpace Oral Vanadium Enhances the Catabolic Effects of Central Leptin in Young Adult Rats Endocrinology, January 1, 2006; 147(1): 493 - 501. [Abstract] [Full Text] [PDF]

				M.-D. Chen, V. C. Yang, P. S. Alexander, P.-Y. Lin, and Y.-M. Song Effects of Selected Minerals on Leptin Secretion in Streptozotocin-Induced Hyperglycemic Mice Experimental Biology and Medicine, October 1, 2001; 226(9): 836 - 840. [Abstract] [Full Text] [PDF]

				I. Goldwaser, J. Li, E. Gershonov, M. Armoni, E. Karnieli, M. Fridkin, and Y. Shechter L-Glutamic Acid gamma -Monohydroxamate. A POTENTIATOR OF VANADIUM-EVOKED GLUCOSE METABOLISM IN VITRO AND IN VIVO J. Biol. Chem., September 10, 1999; 274(37): 26617 - 26624. [Abstract] [Full Text] [PDF]

				S. Verma, M. C. Cam, and J. H. McNeill Nutritional Factors that Can Favorably Influence the Glucose/Insulin System: Vanadium J. Am. Coll. Nutr., February 1, 1998; 17(1): 11 - 18. [Abstract] [Full Text] [PDF]

				B. Lu, D. Ennis, R. Lai, E. Bogdanovic, R. Nikolov, L. Salamon, C. Fantus, H. Le-Tien, and I. G. Fantus Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4) J. Biol. Chem., September 14, 2001; 276(38): 35589 - 35598. [Abstract] [Full Text] [PDF]